Increased Risk Prostate Cancer CombAT Co / Bostwick Laboratories / Urology UT Southwestern Medical Center Risk Management / /
Country
United States / /
Event
FDA Phase / /
Facility
Jefferson University / Chapel Hill / GU Medical Oncology MD Anderson Cancer Center / University High Grade Cancers / Biostatistics University of North Carolina / University of Colorado School / /
MedicalCondition
cancers / Cancer / BPH / Most cancers / Low Grade Prostate Cancer / high grade cancers / detectable prostate cancer / GSK A3 Prostate Cancer / Prostate Cancer / low grade cancers / /
MedicalTreatment
radiotherapy / drug therapy / surgery / /
NaturalFeature
Chapel Hill / /
Organization
University of Colorado School of Medicine Financial Disclosure / Division of Urologic Surgery Washington University High Grade Cancers / PSA / Professional Squash Association / MD SVP / U.S. Food and Drug Administration / Jefferson University / University of North Carolina / Chapel Hill / American Cancer Society / MD VP / /
Person
Gerald L. Andriole / Paolo Paoletti / Anne M. Phillips / Christopher Logothetis / David Bostwick / Scott Lucia / /
Position
Medicine Development Leader / Associate Professor / Chief / Professor and Chairman / Professor / MBA Pathologist / CEO / Chair / Department of GU Medical Oncology / Professor of Medicine / /
ODAC 1Dec10 Avodart GSK Slides